XTL Biopharmaceuticals Ltd.

Prospectus • May 22, 2006

C004	��� �� �� ������������� ��"�		2
Public	X T L BIOPHARMACEUTICALS LTD
	4312	Corporation no: 520039470
	Stock Exchange/Market: ��� �� ��
	1996
	352	Hasapir 3 , Nes Ziona 76100 , ,
	Tel: 08-9304444 , Fax: 08-9304445
	E.mail address: rcohen@xtlbio.com	Date of transmission: 22/05/2006
		Time of broadcast: 19:38 16:54:23
		Reference: 2006-02-065940

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate report on other matterDon't use this form if there is more adequate one

XTL BIOPHARMACEUTICALS LTD. PUBLISHES PROSPECTUS FOR SECURITIES ISSUED PURSUANT TO THE PRIVATE PLACEMENT COMPLETED IN MARCH 2006
Attached file 07-06Publish_Prospectus_Announcement_22May06_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 30/03/2006
- - -
Name of the Signatory : Burgin Jonathan , , Position of Signatory in the reporting corporation: Chief Financial Officer
Hasapir Telephone: 08-9304440 , Facsimile: 08-9300659 , E-mail: jburgin@xtlbio.com